Hollencrest Securities »

Seelos Therapeutics Ord shares owned by Hollencrest Securities

Quarter-by-quarter ownership of Seelos Therapeutics Ord (SEEL) shares owned by Hollencrest Securities from 13F filings

Historical chart of Hollencrest Securities investment in Seelos Therapeutics Ord

Tip: Access up to 7 years of quarterly data

All positions including Seelos Therapeutics Ord held by Hollencrest Securities consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Seelos Therapeutics Ord by Hollencrest Securities

Quarter filed Position value Share count Share price at filing
2024-03-31 $50 86 0.59
2023-12-31 $119 86 1.40

More positions owned by Hollencrest Securities

Vanguard S&p 500 Etf Etf (VOO)
Apple Stock (AAPL)
Spdr S&p 500 Etf Trust Etf (SPY)
Invesco Qqq Trust Series I Etf (QQQ)
Invesco Nasdaq 100 Etf Etf (QQQM)
Unitedhealth Group Stock (UNH)
Microsoft Corp Stock (MSFT)
Berkshire Hathaway Inc Del Cl A Stock (BRK.A)
Costco Whsl Corp Stock (COST)
United Parcel Service Inc Cl B Stock (UPS)
Alphabet Inc Cap Stk Cl A Stock (GOOGL)
Ishares Core S&p 500 Etf Etf (IVV)
Technology Select Sector Spdr Fund Etf (XLK)
Home Depot Stock (HD)
Salesforce Stock (CRM)

View all positions for Hollencrest Securities

Top funds holding Seelos Therapeutics Ord

Wealth Effects
Vanguard Group
Balyasny Asset Management
Jeffrey L. Gendell
Modera Wealth Management
Citadel Advisors
Lynwood Capital Management
Strategic Family Wealth Counselors
Two Sigma Investments
CRA Financial Services
Wealth Enhancement Advisory Services
Advisor Group Holdings
Carmichael Hill & Associates
Bank of America Corporation
Jpmorgan Chase & Co

View all funds holding Seelos Therapeutics Ord